Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression
出版年份 2020 全文链接
标题
Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression
作者
关键词
Carrier-free delivery system, Immunogenic cell death, PD-L1 knockdown, Reversion of immunosuppression, Combination therapy
出版物
Nano Today
Volume 35, Issue -, Pages 100924
出版商
Elsevier BV
发表日期
2020-07-15
DOI
10.1016/j.nantod.2020.100924
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Facile Hydrophobization of siRNA with Anticancer Drug for Non-Cationic Nanocarrier-Mediated Systemic Delivery
- (2019) Congfei Xu et al. NANO LETTERS
- Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy
- (2019) Fakhrossadat Emami et al. MOLECULAR PHARMACEUTICS
- Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
- (2019) Hua Huang et al. NANO LETTERS
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- Functional T cell activation by smart nanosystems for effective cancer immunotherapy
- (2019) Weijing Yang et al. Nano Today
- Recent advances in nanosized drug delivery systems for overcoming the barriers to anti-PD immunotherapy of cancer
- (2019) Xiaochen Liu et al. Nano Today
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Strings Significantly Improved the Gene Transfection Efficiency of Polycations
- (2018) Huapan Fang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Green Tea Catechin Dramatically Promotes RNAi Mediated by Low-Molecular-Weight Polymers
- (2018) Wanwan Shen et al. ACS Central Science
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery
- (2016) Na Liu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer
- (2016) Takehito Shukuya et al. Journal of Thoracic Oncology
- Polyprodrug Amphiphiles: Hierarchical Assemblies for Shape-Regulated Cellular Internalization, Trafficking, and Drug Delivery
- (2013) Xianglong Hu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Feng Wang et al. ACS Nano
- In vivo modulation of dendritic cells by engineered materials: Towards new cancer vaccines
- (2011) Jaeyun Kim et al. Nano Today
- Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis
- (2007) Ping Zhang et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now